About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clinical Trials LeukemiaGeorgia

Leukemia Clinical Trials in Georgia

Find 34 clinical trials for leukemia near Georgia. Connect with research centers in your area.

All Leukemia trials nationwide All trials in Georgia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 1-20 of 34 trials

TerminatedA Safety and Tolerability Study of CDX-301 With or Without Plerixafor for Stem Cell Mobilization in Matched Related Allogeneic Donor/Recipient Sibling Transplant PairsThis is an open-label, multicenter, prospective pilot study of CDX-301 with or without plerixafor as a stem cell mobilizer for allogeneic transplantation (stem cells that come…NCT02200380·Los Angeles, California and 7 others CompletedS9910, Collecting and Storing Blood and Bone Marrow Samples From Patients With Hematologic CancerRATIONALE: Collecting and storing samples of blood and bone marrow from patients with cancer to study in the laboratory may help doctors learn more about diagnosing cancer and how…NCT00919425·Fort Smith, Arkansas and 291 others

Page 1 of 2Next

Leukemia Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

CompletedPost-transplant Cyclophosphamide and Sirolimus Following Reduced Intensity Conditioning (RIC) TransplantThis trial will evaluate the safety and efficacy of post-transplant Cy and sirolimus following reduced intensity allogeneic SCT.NCT01244906·Atlanta, Georgia

CompletedFludarabine, Cyclophosphamide, and Total-Body Irradiation in Treating Patients Who Are Undergoing a Donor Bone Marrow Transplant for Hematologic CancerRATIONALE: Giving low doses of chemotherapy, such as fludarabine and cyclophosphamide, and radiation therapy before a donor bone marrow transplant helps stop the growth of cancer…NCT00134004·Atlanta, Georgia and 2 others

CompletedMK2206 in Treating Younger Patients With Recurrent or Refractory Solid Tumors or LeukemiaThis phase I trial is studying the side effects, best way to give, and best dose of Akt inhibitor MK2206 (MK2206) in treating patients with recurrent or refractory solid tumors or…NCT01231919·Birmingham, Alabama and 24 others

Completed3-AP Followed By Fludarabine In Treating Patients With Relapsed or Refractory Acute or Chronic Leukemia or High-Risk Myelodysplastic SyndromeRATIONALE: Drugs used in chemotherapy, such as fludarabine, work in different ways to stop cancer cells from dividing so they stop growing or die.NCT00077558·Atlanta, Georgia and 3 others

CompletedTotal Body Irradiation/Fludarabine Based Ablative Haploidentical Transplant for Hematologic DiseasesIn this study, patients will receive a myeloablative preparative regimen consisting of fludarabine and total body irradiation (TBI), followed by a T cell replete, mobilized…NCT01336712·Atlanta, Georgia

Active not recruitingHLA-Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation With Reduced Dose Post Transplantation Cyclophosphamide GvHD ProphylaxisThe goal of this clinical trial is to determine the effectiveness of Reduced Dose Post-Transplant Cyclophosphamide (PTCy) in patients with hematologic malignancies after receiving…NCT06001385·Phoenix, Arizona and 31 others

Active not recruitingA First-in-Human Study of HLA-Partially to Fully Matched Allogenic Cryopreserved Deceased Donor Bone Marrow Transplantation for Patients With Hematologic MalignanciesThe goal of this clinical trial is to determine the safety and feasibility of allogeneic transplantation with bone marrow from a deceased donor in patients with acute and chronic…NCT05589896·Duarte, California and 8 others

CompletedCollecting and Storing Malignant, Borderline Malignant Neoplasms, and Related Samples From Young Patients With CancerThis study is collecting and storing malignant, borderline malignant neoplasms, and related biological samples from young patients with cancer.NCT00898079·Birmingham, Alabama and 191 others

CompletedS9007, Study of Bone Marrow and Blood Samples From Patients With Leukemia or Other Hematopoietic CancersRATIONALE: Studying samples of bone marrow and blood from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify…NCT00996047·Mobile, Alabama and 279 others

CompletedGraft-Versus-Host Disease Prophylaxis in Treating Patients With Hematologic Malignancies Undergoing Unrelated Donor Peripheral Blood Stem Cell TransplantThis randomized phase III trial studies how well graft-vs-host disease (GVHD) prophylaxis works in treating patients with hematologic malignancies undergoing unrelated donor…NCT01231412·Denver, Colorado and 10 others

TerminatedUmbilical Cord Blood (UCB) Transplant, Fludarabine, Melphalan, and Anti-thymocyte Globulin (ATG) in Treating Patients With Hematologic CancerRATIONALE: Giving low doses of chemotherapy before a donor umbilical cord blood transplant helps stop the growth of cancer cells.NCT00827099·Atlanta, Georgia

CompletedAmerican Ginseng in Treating Patients With Fatigue Caused by CancerRATIONALE: American ginseng may reduce fatigue in patients with cancer.NCT00719563·Scottsdale, Arizona and 325 others

CompletedCombination Chemotherapy, Donor Stem Cell Transplant, Tacrolimus, Mycophenolate Mofetil, and Cyclophosphamide in Treating Patients With Hematologic CancerRATIONALE: Giving chemotherapy, such as fludarabine, busulfan, and cyclophosphamide, before a donor peripheral blood stem cell transplant helps stop the growth of cancer cells and…NCT00782379·Atlanta, Georgia

CompletedIpilimumab After Allogeneic Stem Cell Transplant in Treating Patients With Persistent or Progressive CancerThis phase I trial is studying how well ipilimumab works after allogeneic stem cell transplant in treating patients with persistent or progressive cancer.NCT00060372·La Jolla, California and 4 others

CompletedABT-348 as Monotherapy and in Combination With Azacitidine to Treat Advanced Hematologic MalignanciesThe purpose of this study is to determine the safety, pharmacokinetics and maximum tolerated dose of ABT-348 as monotherapy and when given in combination with azacitidine.NCT01110473·Scottsdale, Arizona and 2 others

Active not recruitingHLA-Mismatched Unrelated Donor Hematopoietic Cell Transplantation With Post-Transplantation CyclophosphamideThis is a prospective, multi-center, Phase II study of hematopoietic cell transplantation (HCT) using human leukocyte antigen (HLA)-mismatched unrelated donors (MMUD) for…NCT04904588·Duarte, California and 38 others

CompletedVaccine Therapy in Reducing the Frequency of Cytomegalovirus Events in Patients With Hematologic Malignancies Undergoing Donor Stem Cell TransplantThis randomized phase II trial studies how well vaccine therapy works in reducing the frequency of cytomegalovirus severe infections (events) in patients with hematologic…NCT02396134·Duarte, California and 4 others

TerminatedDonor Stem Cell Transplant in Treating Patients With High-Risk Hematologic CancerRATIONALE: Giving low doses of chemotherapy before a donor stem cell transplant helps stop the growth of cancer cells.NCT00818961·Atlanta, Georgia

Other Conditions in Georgia

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Lymphoma

Clareo Health | Leukemia Clinical Trials in Georgia | 34 Studies